Vanguard Group Inc. Increases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Vanguard Group Inc. grew its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,446,437 shares of the biotechnology company’s stock after acquiring an additional 275,959 shares during the quarter. Vanguard Group Inc. owned about 11.08% of Axon Enterprise worth $5,019,886,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Asset Dedication LLC boosted its position in shares of Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC grew its stake in Axon Enterprise by 1.3% during the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after buying an additional 20 shares during the last quarter. Venturi Wealth Management LLC grew its stake in Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock worth $477,000 after buying an additional 21 shares during the last quarter. Insigneo Advisory Services LLC grew its stake in Axon Enterprise by 1.4% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after buying an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC grew its stake in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after buying an additional 24 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on AXON shares. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group boosted their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the company’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Up 0.3 %

Shares of AXON opened at $560.00 on Monday. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $42.91 billion, a price-to-earnings ratio of 144.70, a PEG ratio of 5.17 and a beta of 1.12. The stock’s 50-day moving average price is $591.90 and its 200-day moving average price is $543.57.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.